中国P站

ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 2091

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page
 
Mikihiro Fujiya
Mikihiro Fujiya

Mikihiro Fujiya
Division of Gastroenterology and Hematology/Oncology
Department of Medicine
Asahikawa Medical University
Japan
Tel. 0166-68-2462
Fax 0166-68-2469
Read Interview session with Mikihiro Fujiya

 
Biography

Mikihiro Fujiya is from Asahikawa Medical University (Academia) Department of Medicine, Division of Gastroenterology and Hematology/Oncology Midorigaoka-higashi Asahikawa, Japan

 
Research Interest

Mikihiro Fujiya research interests include Adenocarcinoma, Adenoma, Adenomatous Polyposis Coli.

Interview

1. How many years have you been associated with the current research?
15 years

2. What is the research topic you are working on now?
脙炉芒聙職脜赂 Host-microbial interaction
脙炉芒聙職脜赂 microRNA and RNA-associated molecules
脙炉芒聙職脜赂 Endoscopy

3. What are attributes for a quality article?
脙炉芒聙職脜赂 I identified effective molecules produced by bacteria (probiotics). The molecules are expected to be used as a new drug for intestinal disorders (Fujiya, Cell H&M, 2007; Segawa, Fujiya, PlosOns, 2011).
脙炉芒聙職脜赂 I identified that miR-18a directly bound to oncogenic protein hnRNP A1 and degraded the protein through autophagolysosomal pathway, leading apoptosis of cancer cells (Fujiya, Oncogene, in press).
脙炉芒聙職脜赂 Image-enhanced endoscopies are useful for diagnosing intestinal disorders including colon cancer, lymphoma and inflammatory bowel diseases (Sato, Fujiya, Endoscopy, 2011; Kashima, Nata, Fujiya, GUT, 2011; Fujiya, Gastrointestinal Endoscopy, 2013; Fujiya, Gastrointestinal Endoscopy, 2014, e.g.).

4. Do you have any research funding (NIH or other national funding) now?
Some national funds are supporting my researches.

5. When did you become an editor of 中国P站 Journal?
Around 3 years ago

6. Where can the journal find the maximum scope in terms of niche?
Novel insights concerning both clinical and basic science

7. What is your greatest career accomplishment?
Associate professor

8. How does the published scientific content assist the potential researchers?
Cost down

9. What is the purpose of serving as an editor?
To promote the journal and learn research topics from submitted journal.

10. Do you have any patents?
Yes.

11. Have you contributed any editorials or papers (any types) to 中国P站 Journals in the past two years?
No.

12. Do you plan to contribute any editorials or papers to 中国P站 Journals in the next year?
Yes.

13. How would you define your experience with 中国P站 Group?
Clinical and basic research of the intestinal tract

14. Your opinion on conducting Editorial Board meetings at related Conferences?
I don’t think the meetings are useful to promote the journal.

15. Would you recommend 中国P站 to your friends or colleagues?
Yes. 16. How do you differentiate Journal of Gastrointestinal & Digestive System with other journals in the field?
It would be better to ask young investigators to submit articles with very low fee.

Top Connection closed successfully.